PBR · Verdict

A summary of rules, not a profit forecast — don’t buy just because of a green verdict.

• ▲ P/E 5.6 vs peer median 6.7 — cheaper than peers
• ▲ P/S 1.4 vs peer median 2.0 — cheaper than peers

• ▲ Piotroski 7/9 — strong financial health
• ▲ ROE 30% — high return on equity
• ▼ Net margin fell: 29.4% → 22.0%
• ▲ Debt / equity 0.92 — moderate debt
• ▲ Free cash flow positive every year

• ▼ Revenue falls -10.5% per year (3 y)
• ▼ Earnings per share falls -18.5% per year (3 y)
• ▲ Analysts raised the earnings forecast by +10.9% in 90 days

• ▼ Over 6 mo weaker than its sector (XLE) by 17%
• ▲ Price above SMA200 — long-term uptrend
• ▲ SMA50 above SMA200 — trend up
• ▲ Over a year +88% vs S&P 500 +11% — stronger than the market

• ▼ Earnings in 8 d — the price may move sharply (≈ ±6.6%)
• ▲ Risk/reward 1:3.5 — the target is farther than the stop
• ▼ Volatility 38% per year — much higher than the market (13%)

• ▲ Consensus of 13 analysts — buy

• ▲ S&P 500 above SMA200 — the market is in an uptrend
• ▲ Sector (XLE) above SMA200 — in an uptrend
• ▲ Sector (XLE) over 3 mo is stronger than the market by 17%